Government of India has formulated a scheme namely “Promotion of Research and Innovation in Pharma MedTech Sector” The industry, academia and policy makers need to work together to create a future-ready workforce Policymakers and Industry Experts advocate closer collaboration and partnerships between Industry and Academia in MedTech Sector Visit of G-20 delegates at
Gujarat is committed to provide support to MedTech & pharma industry; urges investment by industry: Bhupendrabhai Patel GANDHINAGAR, 17 August 2023: Dr Mansukh Mandaviya, Minister for Health & Family Welfare and Chemicals & Fertilizers, Govt of India inaugurated India’s 1st ever MedTech Expo organized by the Department of Pharmaceuticals, Government
Generic medicine’s share in Pharma to be more than 50%: Dr. Mansukh Mandaviya Indian Medical Devices sector to play an important role in achieving Atmanirbhar Bharat mission: Shri Bhagwanth Khuba India’s 1 st ever MedTech Expo to be held from 17th to 19th August in Gandhinagar, Gujarat Underlining the intent of the Central
Rana was earlier with Sun Pharma Consumer Healthcare for 6 years as Head of Marketing & eCommerce Former Sun Pharma Consumer Healthcare senior executive Tarundeep Singh Rana has joined Zydus Healthcare Limited as the Chief Marketing Officer. He was with Sun Consumer Healthcare for 6 years
National: After the phenomenal success of the first edition, a revised edition of the book ‘The Perfect Pill: 10 Steps to Build a Strong Healthcare Brand’ by Gauri Chaudhari was launched worldwide recently. The book elaborates on brand-building concepts and suggests necessary steps before applying
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, announced it has received extended indication approval from the Drugs Controller General of India
The company has consolidated its position in GCC, ASEAN, Balkan and Caribbean regions with marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago for important chemotherapy drugs With this, the number of marketing approvals for its oncology products across 75 countries has gone
Syngene (or the “Company”) today announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis Biopharma Limited (SBL). The companies have entered into a binding term sheet and, on completion of the transaction, the site will add 20,000 liters of installed
MedTech Policy Conclave 2023, organized after the introduction of the National Medical Devices Policy, gets a robust response from all stakeholders who underpinned the major pain points and the way forward MedTech Policy Mahotsava Conclave 2023, organized by Medgate Today, witnessed a remarkable turnout
Marking a major step in the global expansion strategy of Venus Remedies through its oncology products, this marketing authorisation from the largest GCC market will enable Venus Remedies to establish a strong foothold in GCC and MENA regions In a decisive step towards making its
